The global brachioplasty market size is expected to reach USD 2.32 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.1% from 2023 to 2030. The primary factors driving the growth are the increasing weight-loss surgeries across developed regions, a growing correlation between self-esteem and obesity, and technological advancements in non-surgical techniques.
According to the American Society for Metabolic and Bariatric Surgery, 256,000 weight loss surgeries were performed in the U.S. in 2019. Additionally, rising technological advancements in non-surgical procedures for brachioplasty will offer additional benefits compared to surgical procedures. For instance, in March 2023, Sentient, LLC received product approval from the U.S. FDA for its Sentient Sculpt, a non-invasive electromagnetic wave treatment for cellulite reduction.
Moreover, different types of medical literature are being recognized, propelling the safety of weight-loss surgeries in the geriatric population. The senior population would reach an estimated 71 million by 2030 in the U.S., from the current 54.1 million in 2022. Players operating in the market can readily target this demographic,
COVID-19 negatively impacted the brachioplasty industry as various elective surgical procedures were halted, and beds were assigned to COVID-19 patients. According to the American Society of Plastic Surgeons, brachioplasty procedures in the U.S. decreased by 17% in 2020. However, the market recovered from the pandemic losses in 2021. According to the National Institute of Health article, cosmetic and aesthetic procedures increased by 29.7% in 2021 from 2019.
Request a free sample copy or view report summary: Brachioplasty Market Report
The market in the healthcare industry was estimated at USD 1.35 billion in 2022 and is expected to reach USD 2.32 billion in 2030
In 2022, North America dominated the market and accounted for a revenue share of 38.47%. The growth is driven by the increasing acceptability of cosmetic procedures and the availability of seasoned professionals in the region
Based on procedure, the surgical segment dominated the brachioplasty industry with a revenue share of 75.20% in 2022, attributed to various benefits associated with the procedure, such as better effectivity and long-lasting than non-surgical alternatives
Based on end-use, the cosmetic surgery clinics segment dominated the market with a revenue share of 63.47% in 2022. It is due to the shorter waiting time and specialized focus on aesthetics and beauty
Some of the key market players are New York Plastic Surgical Group; Westlake Dermatology & Cosmetic Surgery; Nazarian Plastic Surgery; Ruby Surgery & Aesthetics; Cadogan Clinics; UK Aesthetics; B. Care Medical Center; Centre For Surgery; UK Healthcare Aesthetics Center; and Marroquin & Sandoval Plastic Surgery
Grand View Research has segmented the global brachioplasty market based on procedure, end-use, and region:
Brachioplasty Procedure Outlook (Revenue, USD Million, 2018 - 2030)
Surgical
Non-Surgical
Brachioplasty End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Cosmetic Surgery Clinics
Brachioplasty Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Brachioplasty Market
New York Plastic Surgical Group
Westlake Dermatology & Cosmetic Surgery
Nazarian Plastic Surgery.
Ruby Surgery & Aesthetics
Cadogan Clinics
UK Aesthetic
B. Care Medical Center
Centre For Surgery
UK Healthcare Aesthetics Center
Marroquin & Sandoval Plastic Surgery
"The quality of research they have done for us has been excellent..."